Scarica l'app Stockscreener
29.72
1.36%
-0.35
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GPCR Giù?
Forum
Previsione
Precedente Chiudi:
$30.07
Aprire:
$30.15
Volume 24 ore:
57,694
Relative Volume:
0.06
Capitalizzazione di mercato:
$1.71B
Reddito:
-
Utile/perdita netta:
$-100.44M
Rapporto P/E:
-13.39
EPS:
-2.22
Flusso di cassa netto:
$-105.32M
1 W Prestazione:
+3.42%
1M Prestazione:
+41.85%
6M Prestazione:
+86.54%
1 anno Prestazione:
-22.60%
Intervallo 1D:
$29.46
$30.45
Intervallo di 1 settimana:
$27.93
$30.93
Portata 52W:
$13.22
$42.57
Structure Therapeutics Inc Adr Stock (GPCR) Company Profile
Nome
Structure Therapeutics Inc Adr
Settore
Industria
Telefono
(628) 229-9277
Indirizzo
611 GATEWAY BLVD SUITE 223, SOUTH SAN FRANCISCO
Confronta GPCR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GPCR
Structure Therapeutics Inc Adr
|
29.76 | 1.73B | 0 | -100.44M | -105.32M | -2.22 |
|
VRTX
Vertex Pharmaceuticals Inc
|
405.88 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.52 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
544.00 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
795.95 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
326.40 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Structure Therapeutics Inc Adr Stock (GPCR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-02 | Iniziato | Citigroup | Buy |
| 2025-02-28 | Iniziato | William Blair | Outperform |
| 2025-01-08 | Iniziato | Stifel | Buy |
| 2024-12-04 | Iniziato | H.C. Wainwright | Buy |
| 2024-09-23 | Iniziato | Morgan Stanley | Overweight |
| 2024-05-21 | Iniziato | JP Morgan | Overweight |
| 2024-04-09 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-10-19 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-07-27 | Iniziato | Piper Sandler | Overweight |
| 2023-05-25 | Ripresa | Jefferies | Buy |
| 2023-02-28 | Iniziato | BMO Capital Markets | Outperform |
| 2023-02-28 | Iniziato | Guggenheim | Buy |
| 2023-02-28 | Iniziato | Jefferies | Buy |
| 2023-02-28 | Iniziato | SVB Securities | Outperform |
Mostra tutto
Structure Therapeutics Inc Adr Borsa (GPCR) Ultime notizie
Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Structure Therapeutics' (GPCR) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Structure Therapeutics Inc. Sponsored ADR $GPCR Shares Purchased by Signaturefd LLC - Defense World
Piper Sandler Keeps Their Buy Rating on Structure Therapeutics, Inc. Sponsored ADR (GPCR) - The Globe and Mail
Layoff Tracker: CSL Vifor, Bolt Cut Staff - BioSpace
Citius Oncology (NASDAQ:CTOR) and Structure Therapeutics (NASDAQ:GPCR) Head to Head Survey - Defense World
Structure Therapeutics (NASDAQ:GPCR) Trading Down 4.3%Should You Sell? - MarketBeat
ABSSSI Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Glenmark Pharma, Melinta Therapeutics, Sandoz Inc, Paratek Pharma, AbbVie Inc., Allergan PLC, Merck & Co. Inc., Pfizer - The Globe and Mail
ABSSSI Market to Reach New Heights in Growth by 2034, - openPR.com
Structure Therapeutics (NASDAQ:GPCR) Trading 5.8% HigherTime to Buy? - MarketBeat
Lunai Bioworks Unveils New Corporate Identity, Streamlined Capital Structure, and Strategic Focus on AI-Powered Therapeutics and Biodefense - The Globe and Mail
Banque Pictet & Cie SA Sells 11,365 Shares of Structure Therapeutics Inc. Sponsored ADR $GPCR - MarketBeat
Structure Therapeutics stock rating reiterated at Buy by H.C. Wainwright - Investing.com India
Interactive Brokers Group, Inc. $IBKR Shares Acquired by Swedbank AB - Defense World
Sumitomo Mitsui DS Asset Management Company Ltd Makes New Investment in Confluent, Inc. $CFLT - Defense World
Exchange Traded Concepts LLC Buys 1,054 Shares of TKO Group Holdings, Inc. $TKO - Defense World
IFM Investors Pty Ltd Has $3.42 Million Stock Position in Annaly Capital Management Inc $NLY - Defense World
MongoDB, Inc. $MDB Shares Acquired by IFM Investors Pty Ltd - Defense World
Wealth Enhancement Advisory Services LLC Grows Stock Holdings in VanEck Semiconductor ETF $SMH - Defense World
Voya Investment Management LLC Buys 1,696 Shares of PriceSmart, Inc. $PSMT - Defense World
Voya Investment Management LLC Lowers Stock Position in Dutch Bros Inc. $BROS - Defense World
Vanguard Total International Bond ETF $BNDX Shares Bought by Exchange Traded Concepts LLC - Defense World
IFM Investors Pty Ltd Boosts Position in Evergy Inc. $EVRG - Defense World
IFM Investors Pty Ltd Grows Holdings in Trimble Inc. $TRMB - Defense World
UnitedHealth Group Incorporated $UNH Shares Acquired by Exchange Traded Concepts LLC - Defense World
DNOW Inc. $DNOW Shares Purchased by Exchange Traded Concepts LLC - Defense World
Exchange Traded Concepts LLC Purchases 22,809 Shares of Structure Therapeutics Inc. Sponsored ADR $GPCR - Defense World
IFM Investors Pty Ltd Purchases 2,676 Shares of Deckers Outdoor Corporation $DECK - Defense World
Exchange Traded Concepts LLC Has $1.14 Million Holdings in Molina Healthcare, Inc $MOH - Defense World
Exchange Traded Concepts LLC Acquires New Holdings in Vanguard Total Stock Market ETF $VTI - Defense World
Pallas Capital Advisors LLC Buys New Shares in Keysight Technologies Inc. $KEYS - Defense World
Parallel Advisors LLC Takes $171,000 Position in Structure Therapeutics Inc. Sponsored ADR $GPCR - Defense World
BICO Group AB (publ) (OTCMKTS:CLLKF) Stock Price Down 10.2% – Should You Sell? - Defense World
Structure Therapeutics (NASDAQ:GPCR) Shares Gap UpShould You Buy? - MarketBeat
Biotech Stocks Moving Premarket: QLGN, MBX, HSDT, And Other Gainers & Losers - RTTNews
iShares U.S. Insurance ETF $IAK Shares Sold by Focus Financial Network Inc. - Defense World
xFOREST Therapeutics and Axcelead DDP Launch Joint Research Initiative on RNA Structure-Targeted Small Molecule Drug Discovery - BioSpace
Structure Therapeutics Inc. (GPCR) Eyes Major 2025 Catalyst With Phase 2b Obesity Data - Insider Monkey
Relay Therapeutics, Inc. (RLAY) Shows Breakthrough Breast Cancer Results With RLY-2608 - Yahoo Finance
Structure Therapeutics (NASDAQ:GPCR) Trading 6.3% HigherHere's What Happened - MarketBeat
Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR) Receives $75.71 Average Price Target from Brokerages - MarketBeat
Analysts Are Bullish on These Healthcare Stocks: Scholar Rock Holding (SRRK), Akero Therapeutics (AKRO) - The Globe and Mail
Top 10 AI-Powered Biotech Stocks to Buy Now - Insider Monkey
Promising Market Potential for Structure Therapeutics: Buy Rating Backed by Superior Trial Results and Market Opportunities - TipRanks
Structure Therapeutics stock rating reiterated by Cantor Fitzgerald - Investing.com
Structure Therapeutics stock rating reiterated by JMP, citing positive safety data - Investing.com
Structure Therapeutics, Inc. Sponsored ADR (GPCR) Gets a Buy from LifeSci Capital - The Globe and Mail
Zimmer Partners LP Purchases 43,876 Shares of Structure Therapeutics Inc. Sponsored ADR $GPCR - MarketBeat
Exome Asset Management LLC Decreases Position in Structure Therapeutics Inc. Sponsored ADR $GPCR - MarketBeat
Equities Analysts Set Expectations for GPCR Q3 Earnings - MarketBeat
Structure Therapeutics Inc Adr Azioni (GPCR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.81%
0.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):